+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 79Years
All Genders
ID07309614

Evaluating Dupilumab for Early Asthma Control to Achieve Remission in Adults with Moderate Type-2 Inflammatory Asthma

Led by Université de Sherbrooke · Updated on 2026-10-02

150

Participants Needed

5

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether early treatment with the asthma medication dupilumab can help adults with moderate asthma achieve complete control of their condition, called remission. This study focuses on people aged 18 to 79 who have experienced at least one asthma attack requiring steroid pills in the past two years and have high markers of inflammation, but do not yet have severe asthma. The goal is to see if starting dupilumab earlier can prevent attacks and lung damage compared to current treatments that begin after asthma worsens. Participants receive either dupilumab or placebo injections every two weeks for one year, in addition to their regular asthma medications. The study is double-blind, so neither participants nor doctors know who receives the real medication. The treatment period tests if dupilumab increases the chances of remission compared to standard inhaled steroid adjustments. The trial is conducted in Canada, the United Kingdom, and Australia with 150 participants. During the study, participants attend clinic visits every three months for breathing tests, questionnaires, and safety monitoring. Researchers measure lung function, asthma attacks, medication use, symptoms, quality of life, and inflammatory markers over the year. The main outcome is a win ratio based on remission criteria from week 4 to week 56. Safety and treatment effects are closely followed throughout the study period.

CONDITIONS

Brief Title

A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here